🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

UPDATE 1-UK Stocks-Factors to watch on April 23

Published 04/23/2021, 02:51 PM
Updated 04/23/2021, 03:00 PM
© Reuters.
UK100
-
AZN
-
AAL
-
PSON
-
FGP
-
UK100
-
AZN
-

(Adds futures, news items)
April 23 (Reuters) - Britain's FTSE 100 .FTSE index is
seen opening 27 points lower at 6,911 points on Friday,
according to financial bookmakers, with futures FFIc1 down
0.5% ahead of cash market open.

* FIRSTGROUP: FirstGroup Plc FGP.L agreed to sell its
North American school bus and bus contracting businesses to EQT
Infrastructure for $4.6 billion including debt, the UK-based
transport operator said . * RETAIL SALES: British retail sales rose by 5.4% in March
from February ahead of the re-opening of non-essential shops
this month, official data showed. * BORROWING: Britain's government borrowed 303.1 billion
pounds in the financial year which ended last month, as it
resorted to a huge surge in spending and tax cuts to offset the
economic hit from the COVID-19 pandemic. * CLIMATE CHANGE: Climate activists protested outside the
Lloyd's of London insurance market, dumping a load of fake coal
outside its headquarters as part of a campaign against insuring
fossil fuel mining. * ANGLO AMERICAN: Anglo American Plc AAL.L has not kept
workers fully informed of plans to restart a coal mine in
Queensland nearly a year after a blast injured five people, a
union official said, but the company called the comments
unfounded. * CONSUMER SENTIMENT: British consumer sentiment rose to its
highest since the start of the COVID pandemic this month as the
economy reopened partially, a closely watched survey showed, but
the increase was smaller than economists had expected.
* ASTRAZENECA: Australia's Minister for Trade has urged
AstraZeneca (NASDAQ:AZN) AZN.L to dispatch 1 million COVID-19 vaccine doses
to Papua New Guinea amid concerns about the spread of the virus
there, saying the EU had pledged no hindrance to the exports.
* ASTRAZENECA: Britain's medicines regulator on Thursday
said there had been 168 major blood clots following a dose of
AstraZeneca's COVID-19 vaccine, a rate of 7.9 clots per million
doses, a jump in incidence from the previous week's figure.
* ASTRAZENECA: The European Commission said on Wednesday no
decision had yet been taken on whether to launch legal action
against AstraZeneca, after Ireland's health minister said the
case had been initiated.
* PEARSON: Education group Pearson Plc PSON.L said on
Thursday Chairman Sidney Taurel intends to retire and step down
from the board no later than next year's annual general meeting.
* REGULATOR: Britain's financial regulator said on Thursday
it will rethink how consumers should be protected after a surge
in online scams since people were forced to work from home due
to COVID-19 restrictions. * OIL: Oil prices rose, buoyed by hopes demand will recover
as economic growth picks up and lockdowns ease, but worries
about India's surging second wave of COVID-19 cases limited
gains. * COPPER: Copper prices were on track for their third
straight week of gains, as a weaker dollar made greenback-priced
metals cheaper and more appealing to holders of other
currencies. * Britain's FTSE 100 ended higher on Thursday on higher
retail stocks as last week saw a jump in footfalls and a weaker
pound, while mid-caps rose to their best day in two weeks led by
gains in construction company Morgan Sindall. For more on the factors affecting European stocks, please
click on: LIVE/
TODAY'S UK PAPERS
> Financial Times PRESS/FT
> Other business headlines PRESS/GB

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.